Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1b Clinical Trial of IV OKN-007 in a Pilot Cohort of Human Recurrent Malignant Glioma Patients

NCT01672463 is registered in ClinicalTrials.gov with Oblato, Inc. as lead sponsor.

NCT NCT01672463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01672463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1b Clinical Trial of IV OKN-007 in a Pilot Cohort of Human Recurrent Malignant Glioma Patients
Lead sponsor
Oblato, Inc.
Phase
Phase 1
Overall status
Unknown status
Start date
December 31, 2012
Completion date
October 31, 2023
Enrollment
31 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent malignant glioma